Demographics |
Name, national ID number, contact details, gender, date of birth, employment status, alcohol use, smoking history, ethnicity and education level |
Clinical visit data |
Date of visit (scheduled and actual), TB screening, urine analysis, vital signs, height, weight, description and duration of new symptoms and systems-based clinical examination (e.g. cardiology, neurology, and respiratory) |
Laboratory results |
ART initiation and monitoring bloods, including CD4 count, HIV viral load, full blood counts, liver function tests, renal function tests, TB microscopy and culture results, lactate levels and glucose and lipid profiles |
Medication history |
Date of start and stop of ART and non-ART medications, reasons for treatment discontinuation and self-reported treatment adherence |
Clinical diagnoses |
Pregnancy, opportunistic infections including TB, hepatitis, PCP, AIDS-related malignancies including Kaposi sarcoma, ART toxicities including peripheral neuropathy, anaemia, hyperlactataemia/lactic acidosis and lipoatrophy |